Menu

Blog Posts

MedPAC’s Call to Replace Medicare DSH Formula Could Spill Over into 340B

In Federal, Research/Reports544 Views Tom Mirga
MedPAC report to the Congress title page
MedPAC this week recommended replacing the Medicare DSH patient adjustment percentage for Medicare hospital payment purposes. The 340B program uses the same calculation as one of its hospital eligibility criteria.

Congressional Medicare advisers yesterday formally recommended replacing the formula Medicare uses to distribute extra payments to safety net hospitals that disproportionately serve low-income and/or uninsured beneficiaries.

The 340B program uses the same calculation—the Medicare disproportionate share adjustment percentage—to

…
Read More »

CMS Announces First Drugs Subject to Medicare Inflation Rebates, Issues Guidance Addressing 340B and Medicare Negotiated Drug Prices

In Federal, Regulatory907 Views Laura Gilcrest and Tom Mirga
CMS building
CMS on Tuesday announced the first 27 prescription drugs that will be subject to Medicare Part B inflation rebates, and on Wednesday released guidance on the new Medicare drug price negotiation program—including its intersection with 340B.

The U.S. Centers for Medicare & Medicaid Services Tuesday announced the first 27 prescription drugs that will be subject to Medicare Part B inflation rebates, a list that includes AbbVie’s blockbuster arthritis drug Humira, which generated $5.6 billion

…
Read More »

HRSA Wants Reporting Requirements on Use of 340B Savings and Compliance and Reporting Requirements on Use of Contract Pharmacies

In Federal, Legislative1142 Views Tom Mirga
HRSA building and signage
HRSA is asking Congress for regulatory power to establish “reporting requirements and definitions for the use of [340B] savings and contract pharmacy utilization.”

The U.S. Health Resources and Services Administration has asked Congress for general rulemaking authority over the 340B program so it can establish “reporting requirements and definitions for the use of [340B] savings and contract pharmacy utilization.”

The Biden

…
Read More »

340B Prime Vendor Apexus Asks Court to Dismiss AIDS Healthcare Foundation’s Breach of Contract Suit

In Federal, Judicial362 Views Tom Mirga
USDC Central District of California building with Great Seal of the United States
The 340B prime vendor Apexus asked the federal district court in Los Angeles to dismiss AIDS Healthcare Foundation's claims that Apexus failed and refused to negotiate sub-ceiling discounts on HIV/AIDS drugs.

Apexus, the federally contracted 340B prime vendor, asked a federal district judge in Los Angeles on Friday to dismiss AIDS Healthcare Foundation’s lawsuit alleging that Apexus has failed and refused to negotiate sub-ceiling 340B discounts on HIV/AIDS prescription

…
Read More »

340B Stakeholders Testify on Conn. Governor’s First-of-Its-Kind Multi-Pronged 340B Legislation

In Legislative, State236 Views Laura Gilcrest
Connecticut state capitol dome
Connecticut lawmakers heard testimony yesterday on Gov. Ned Lamont’s (D) bill addressing hospitals' 340B revenue, pharma restrictions on 340B contract pharmacy use, and PBM discrimination against 340B entities.

Connecticut 340B stakeholders testified at a state legislative hearing Monday on Gov. Ned Lamont’s (D) comprehensive bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager

…
Read More »

News Alert

Some Provider Groups Slam NACHC and PhRMA’s 340B Plan, Others Say They’re Studying it

In Federal, Legislative, News Alert, Pharma Industry, Providers1818 Views Tom Mirga
NACHC P&I 2023 speaker at podium
Lt. Cmdr. Emeka Egwim (left), Director of HRSA's Office of Pharmacy Affairs, spoke this morning on 340B Day at NACHC's annual Policy & Issues Forum in Washington, D.C.

A large HIV/AIDS health care group, a Democratic 340B provider ally in Congress, and three national hospital groups lambasted community health centers and drug makers’ historic announcement yesterday that they are working together to remake the 340B program.

…
Read More »

U.S. House Subcommittee Expected to Raise 340B During March 28 Hearing

In Federal, Legislative654 Views Tom Mirga
House E&C wordmark
340B is expected to be addressed during a U.S. House Energy & Commerce health subcommittee hearing later this month.

The Republican-led U.S. House Energy & Commerce health subcommittee late yesterday announced a March 28 hearing on “how transparency and competition can lower health care costs for Americans.”

Although the hearing announcement is silent about the 340B

…
Read More »

Breaking News

Major Drug Industry and Health Center Groups Unite to Reform 340B for Patients and “True” Safety-Net Providers

In Breaking, Federal, Legislative, Pharma Industry, Providers3751 Views Tom Mirga
ASAP 340B wordmark
PhRMA, NACHC, and and the National Hispanic Medical Association created a new group, ASAP 340B, and issued a 10-point plan to ensure that the 340B program “benefits patients and true safety-net providers, including rural hospitals.”

Pharmaceutical Research and Manufacturers of America, the National Association of Community Health Centers, and the National Hispanic Medical Association this morning jointly issued a 10-point plan and created a nonprofit group to ensure that the 340B program “benefits

…
Read More »

N.Y. State Judge Dismisses 340B-Related Antitrust Suit Against CVS

In Judicial, State445 Views Tom Mirga
CVS Health signage
A New York State judge dismissed the state attorney general's 340B-related antitrust lawsuit against CVS Health.

A New York State judge has dismissed the state’s antitrust lawsuit alleging that CVS Health illegally makes 340B covered entities use its 340B third party administrator Wellpartner in order to contract with CVS retail and specialty pharmacies to

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer